Louisiana

The Board of Pharmacy held their quarterly meeting on November 17.  

Also in Louisiana, Medicaid announced that another Managed Care Organization (MCO), Humana Healthy Horizons, will be added effective January 1, 2023, offering services to Medicaid recipients. The Medicaid Pharmacy Program will now consist of Medicaid Fee-for-Service (FFS) and six managed care organizations (Aetna, AmeriHealth Caritas, Healthy Blue, Humana Healthy Horizons, Louisiana Healthcare Connections, and UnitedHealthcare).  

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2022-11-18T11:14:23-05:00November 18, 2022|Louisiana|

Massachusetts

A new standing order for over-the-counter (OTC) COVID-19 diagnostic tests has been developed by the Department of Public Health in accordance with M.G.L. c. 94C, s. 19A, which authorizes the issuance of standing orders for licensed pharmacists to dispense a COVID-19 control measures. This standing order is now in effect and should be utilized going forward. Please be aware that the January 14, 2022, Standing Order for Dispensing Over the Counter (OTC) Diagnostic Tests for SARS-CoV-2 is no longer in effect and may no longer be used.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2022-11-18T11:13:48-05:00November 18, 2022|Massachusetts|

Missouri

Quantity limits for albuterol inhalers and nebulizer solutions went into effect on August 28. Adults are now limited to 3 albuterol inhalers (300 rescue doses) every 180 days. Participants of all ages are limited to 120 vials every 2 months. If a provider feels a patient needs albuterol inhalers or nebulizer solutions more than these limits, a letter of medical necessity and progress notes will need to be submitted. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2022-11-18T11:12:31-05:00November 18, 2022|Missouri|

New York

The Department of Health (DOH) has established a webpage with information and resources for pharmacies regarding the transition of the pharmacy benefit from Managed Care to NYRx. The page will be updated regularly. You can also email the DOH with questions about this issue by putting “pharmacy benefit transition” in the subject line. To sign up for the Medicaid Redesign LISTSERV, please click here. 

Also in New York, the DOH issued changes to the prior authorization process and an updated preferred drug list for the NYRx program, effective November 17, 2022. 

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2022-11-18T11:12:00-05:00November 18, 2022|New York|

Ohio

The SPBM (Single Pharmacy Benefit Manager), Gainwell Technologies, sent a communication to pharmacies this week detailing claim recoupments that are planned in the next few weeks to compensate for overpayments in the first three weeks of the migration to the new Medicaid managed care pharmacy system.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2022-11-18T11:11:14-05:00November 18, 2022|Ohio|

Oregon

The Board of Pharmacy is proposing to adopt the following rules. A hearing will be held on November 22 at 9:30 a.m. PT. Written comments may be filed before 4:30 p.m. PT on November 22 via email to pharmacy.rulemaking@bop.oregon.gov. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2022-11-18T11:10:44-05:00November 18, 2022|Oregon|

Texas

Gov. Greg Abbott (R) directed the Texas Education Agency (TEA) and the school superintendents that the COVID-19 vaccine cannot be mandated as part of school entry requirements. Instead, Texas law overrides a recent recommendation from the Centers for Disease Control (CDC) that added the vaccine to immunization schedules for adults and school-aged children. In letters to TEA Commissioner Mike Morath and school superintendents statewide, the Governor explains that his Executive Order No. GA-39, issued on August 25, 2021, allows Texas parents to opt-out of the COVID-19 vaccine for their children and further empowers parents to be the primary decision-makers in their children’s healthcare. Also, the Texas Legislature has enabled parents to opt out of vaccinating their children for health reasons and reasons of conscience through several statutes, including Texas Education Code § 38.01(c)(1), Texas Health & Safety Code §§ 161.004(d), 161.0041 and Texas Human Resources Code § 42.043(d). 

Also in Texas, the Health, and Human Services Commission (HHSC) Vendor Drug Program (VDP) Medicaid is soliciting feedback on its proposed policies related to the transition of the formulary, preferred drug list and prior authorization requirements to managed care organizations, in accordance with state law. The survey must be completed by 5:00 PM CT on December 4, 2022. 

Also in Texas, at the Board of Pharmacy early this month, the Board adopted and proposed several rules. 

Finally in Texas, November 14 was the first day of bill filing for the 2023 legislative session that convenes on January 10, 2023. Shortly after Noon, legislators had filed more than 800 bills. Thousands of pieces of legislation are filed each biennial session, but most never make it into law.  

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2022-11-18T11:09:19-05:00November 18, 2022|Texas|
Go to Top